CN116998593A - Application of lactobacillus plantarum in preparation for improving fish sugar tolerance - Google Patents
Application of lactobacillus plantarum in preparation for improving fish sugar tolerance Download PDFInfo
- Publication number
- CN116998593A CN116998593A CN202311194904.8A CN202311194904A CN116998593A CN 116998593 A CN116998593 A CN 116998593A CN 202311194904 A CN202311194904 A CN 202311194904A CN 116998593 A CN116998593 A CN 116998593A
- Authority
- CN
- China
- Prior art keywords
- lactobacillus plantarum
- group
- liver
- use according
- feed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 240000006024 Lactobacillus plantarum Species 0.000 title claims abstract description 46
- 235000013965 Lactobacillus plantarum Nutrition 0.000 title claims abstract description 46
- 229940072205 lactobacillus plantarum Drugs 0.000 title claims abstract description 46
- 241000251468 Actinopterygii Species 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title abstract description 7
- 241001125889 Micropterus salmoides Species 0.000 claims abstract description 43
- 230000000968 intestinal effect Effects 0.000 claims abstract description 17
- 102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 claims abstract description 6
- 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 claims abstract description 6
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229930186217 Glycolipid Natural products 0.000 claims abstract description 5
- 150000003627 tricarboxylic acid derivatives Chemical class 0.000 claims abstract description 5
- 208000030159 metabolic disease Diseases 0.000 claims abstract description 4
- 244000005700 microbiome Species 0.000 claims description 10
- 230000001105 regulatory effect Effects 0.000 claims description 9
- 150000001720 carbohydrates Chemical class 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 239000008223 sterile water Substances 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 230000001580 bacterial effect Effects 0.000 claims description 4
- 230000008021 deposition Effects 0.000 claims description 4
- 230000000813 microbial effect Effects 0.000 claims description 4
- 230000037361 pathway Effects 0.000 claims description 4
- 238000009472 formulation Methods 0.000 claims description 3
- 230000019491 signal transduction Effects 0.000 claims description 3
- 241000321429 Epinephelus itajara Species 0.000 claims description 2
- 230000013632 homeostatic process Effects 0.000 claims description 2
- 230000002440 hepatic effect Effects 0.000 claims 2
- 210000004185 liver Anatomy 0.000 abstract description 40
- 239000003963 antioxidant agent Substances 0.000 abstract description 3
- 230000003078 antioxidant effect Effects 0.000 abstract description 3
- 239000006041 probiotic Substances 0.000 abstract description 3
- 235000018291 probiotics Nutrition 0.000 abstract description 3
- 230000000529 probiotic effect Effects 0.000 abstract description 2
- 235000021070 high sugar diet Nutrition 0.000 abstract 1
- 229920002472 Starch Polymers 0.000 description 33
- 239000008107 starch Substances 0.000 description 33
- 235000019698 starch Nutrition 0.000 description 26
- 230000014509 gene expression Effects 0.000 description 9
- 230000000694 effects Effects 0.000 description 7
- 239000003925 fat Substances 0.000 description 7
- 150000002632 lipids Chemical class 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 235000014633 carbohydrates Nutrition 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- 241000590020 Achromobacter Species 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 241001446480 Embiotoca jacksoni Species 0.000 description 3
- 241000269794 Lateolabrax Species 0.000 description 3
- 241000269795 Lateolabrax japonicus Species 0.000 description 3
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 3
- 101150014691 PPARA gene Proteins 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000009395 breeding Methods 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 210000005228 liver tissue Anatomy 0.000 description 3
- 229940118019 malondialdehyde Drugs 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 102000016938 Catalase Human genes 0.000 description 2
- 108010053835 Catalase Proteins 0.000 description 2
- 241001051186 Cetobacterium Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 101100463018 Mus musculus Pck1 gene Proteins 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 101150024973 PNPLA2 gene Proteins 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000009360 aquaculture Methods 0.000 description 2
- 244000144974 aquaculture Species 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000010201 enrichment analysis Methods 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 210000003494 hepatocyte Anatomy 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 230000004130 lipolysis Effects 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 210000003934 vacuole Anatomy 0.000 description 2
- 102100039164 Acetyl-CoA carboxylase 1 Human genes 0.000 description 1
- 102100022089 Acyl-[acyl-carrier-protein] hydrolase Human genes 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 238000009631 Broth culture Methods 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 108010039731 Fatty Acid Synthases Proteins 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- 241000605909 Fusobacterium Species 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 101000963424 Homo sapiens Acetyl-CoA carboxylase 1 Proteins 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 235000013958 Lactobacillus casei Nutrition 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000291280 Micropterus floridanus Species 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 108010016731 PPAR gamma Proteins 0.000 description 1
- 241000269799 Perca fluviatilis Species 0.000 description 1
- 102100038831 Peroxisome proliferator-activated receptor alpha Human genes 0.000 description 1
- 102100038825 Peroxisome proliferator-activated receptor gamma Human genes 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 238000010802 RNA extraction kit Methods 0.000 description 1
- 241000040577 Romboutsia Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 102000000019 Sterol Esterase Human genes 0.000 description 1
- 108010055297 Sterol Esterase Proteins 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- XKMRRTOUMJRJIA-UHFFFAOYSA-N ammonia nh3 Chemical compound N.N XKMRRTOUMJRJIA-UHFFFAOYSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 102000023732 binding proteins Human genes 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 230000025938 carbohydrate utilization Effects 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000004136 fatty acid synthesis Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 210000003736 gastrointestinal content Anatomy 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 244000005709 gut microbiome Species 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000007413 intestinal health Effects 0.000 description 1
- 229940017800 lactobacillus casei Drugs 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000002366 lipolytic effect Effects 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- 210000002824 peroxisome Anatomy 0.000 description 1
- 108091008725 peroxisome proliferator-activated receptors alpha Proteins 0.000 description 1
- 229930029653 phosphoenolpyruvate Natural products 0.000 description 1
- DTBNBXWJWCWCIK-UHFFFAOYSA-N phosphoenolpyruvic acid Chemical compound OC(=O)C(=C)OP(O)(O)=O DTBNBXWJWCWCIK-UHFFFAOYSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000013422 transcriptome assay Methods 0.000 description 1
- YWYZEGXAUVWDED-UHFFFAOYSA-N triammonium citrate Chemical compound [NH4+].[NH4+].[NH4+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YWYZEGXAUVWDED-UHFFFAOYSA-N 0.000 description 1
- 239000001393 triammonium citrate Substances 0.000 description 1
- 235000011046 triammonium citrate Nutrition 0.000 description 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/25—Lactobacillus plantarum
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Polymers & Plastics (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Animal Husbandry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Insects & Arthropods (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Marine Sciences & Fisheries (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Birds (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Physiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses application of lactobacillus plantarum in a preparation for improving fish sugar tolerance. The probiotic is Lactobacillus plantarum. The probiotics provided by the invention can regulate the PPAR signal path and the tricarboxylic acid circulating path of the liver by maintaining the intestinal flora steady state of the largemouth black bass, thereby relieving the liver glycolipid metabolic disorder of the largemouth black bass caused by high-sugar diet feeding and improving the antioxidant capacity of the liver. The invention provides a new solution for improving the sugar tolerance capability and healthy cultivation of carnivorous fishes.
Description
Technical field:
the invention belongs to the field of aquaculture, and particularly relates to application of lactobacillus plantarum preparations in improving fish sugar tolerance.
The background technology is as follows:
carbohydrates, which are one of the essential nutrients in aquatic feeds, are a cheaper source of energy than proteins and fats. The proper amount of carbohydrate is added into the aquatic feed to promote the protein utilization of fish. As a common carbohydrate, starch can act as a binder and granule expander in feed production. Under the background of rising prices of fish meal and fish oil, more carbohydrate is added into the aquatic feed, so that the feed cost can be reduced, the production benefit can be improved, and the green sustainable development of the aquatic product aquaculture industry in China can be ensured.
Because of the difference of the digestion and utilization capacity of different edible fishes on carbohydrate, especially the carnivorous fishes have the worst sugar utilization capacity. Thus, excessive ingestion of saccharides leads to an increase in blood glucose levels of the black bass, excessive deposition of liver glycogen and lipids, and ultimately, metabolic disorders of the liver. Enteric microorganisms have proven useful against obesity and metabolic disorders. Research has shown that beneficial microorganisms promote growth and immune responses in fish by improving intestinal morphology and altering intestinal microbial flora. Lactobacillus plantarum (Lactobacillus plantarum) has multiple physiological functions and is one of the most potential feeding microecological preparations. Lactobacillus plantarum has been demonstrated to regulate lipid metabolism and alleviate liver injury in mammals, however its functional studies on fish remain scarce.
Lateolabrax japonicus (Micropterus salmoides), commonly known as California perch, belongs to the genus Lateolabrax of the order Lateolabrax, family Sun-fish, and genus Lateolabrax, is a carnivorous fish. The fish feed has the advantages of high growth speed, rich nutrition and great economic value, and gradually becomes one of the most important commercial fishes in China and the most extensive cultivation. In order to meet the rapid development of the largemouth bass breeding industry, compound feed is increasingly used for feeding and breeding in production. In the preparation of the puffed floating feed granule for the largemouth bass, the addition amount of starch is generally not less than 20 percent. Many studies have shown that when the starch level of the feed exceeds 10%, the liver fat content of the micropterus salmoides increases, the antioxidant capacity decreases, and the intestinal health and the growth performance of the micropterus salmoides are also damaged, so that the cultivation income is finally affected. Therefore, the negative effect caused by the high-starch feed is a problem to be solved in the development of the largemouth bass breeding industry.
The invention comprises the following steps:
a first object of the present invention is to provide the use of Lactobacillus plantarum in a formulation for increasing the glucose tolerance of fish.
Preferably, the lactobacillus plantarum is derived from the Guangdong province microorganism strain collection, and the number is GDMCC1.140.
The fish is Lateolabrax japonicus.
Further, the Lactobacillus plantarum was cultured with MRS broth for 48 hours at 37℃and washed three times with sterile water and dissolved in sterile water at a concentration of 10 8 -10 9 CFU/mL。
Further, lactobacillus plantarum is uniformly sprayed into the largemouth bass feed, and the final concentration is about 10 7 CFU/g feed. It is further preferable to spray new bacterial liquid every 48 hours.
After the Lactobacillus plantarum is used for treating the micropterus salmoides for 9 weeks, the microbial composition structure in the intestinal canal of the micropterus salmoides can be improved, the microbial homeostasis of the intestinal canal can be maintained, and the PPAR signal path and the tricarboxylic acid circulating path of the liver can be regulated, so that the abnormal glycolipid metabolism of the micropterus salmoides can be regulated, and the glucose tolerance can be improved.
The invention has at least the following advantages:
1. the invention discloses a lactobacillus plantarum which regulates glycolipid metabolic disturbance by regulating a liver PPAR signal path and a tricarboxylic acid circulating path, so as to relieve liver fat deposition of micropterus salmoides.
2. The invention has important guiding significance for understanding the probiotic function of lactobacillus plantarum and the application of lactobacillus plantarum in healthy cultivation of the black perch.
Drawings
FIG. 1 is the effect of Lactobacillus plantarum on liver mass ratio and liver fat content of micropterus salmoides. (A) Liver volume ratio bar graphs (n=6) of largemouth black bass fed with different groups of feeds; (B) Liver crude fat content bar graph (n=6) of largemouth bass fed with different group feed. LS: a low starch group; HS: a high starch group; HSP's: high starch + lactobacillus plantarum group. * P <0.05, < P <0.01, < P <0.001..
FIG. 2 is the effect of Lactobacillus plantarum on liver health of Lateolabrax japonicus. (A) The liver oxidation resistance index (superoxide dismutase, malondialdehyde and catalase) bar graph (n=6) of the largemouth bass fed with different groups of feeds; (B) Liver section of largemouth black bass fed with different groups of feeds (hematoxylin-eosin staining), red arrow indicates the deviation of the nuclei from the center of the hepatocytes, black arrow indicates lipid vacuoles (n=3). LS: a low starch group; HS: a high starch group; HSP's: high starch + lactobacillus plantarum group. * P <0.05.
Fig. 3 is the effect of lactobacillus plantarum on the composition structure of the intestinal flora of micropterus salmoides (n=3). (A) Feeding intestinal flora OTU Venn diagrams of largemouth bass by different groups of feeds; (B) Intestinal flora diversity bar graphs of largemouth bass fed with different groups of feeds; (C) Intestinal flora distribution at Phyum (Phylum) and Genus level of large-mouth black bass fed with different groups of feeds. LS: a low starch group; HS: a high starch group; HSP's: high starch + lactobacillus plantarum group. * P <0.01.
Fig. 4 is a liver transcriptome KEGG pathway map (Top 30) of different groups of feed fed micropterus salmoides (n=3). LS: a low starch group; HS: a high starch group; HSP's: high starch + lactobacillus plantarum group. .
Fig. 5 is the effect of lactobacillus plantarum on liver gene expression of micropterus salmoides (n=6). (A) Feeding liver lipolysis related gene expression level bar graphs of largemouth black bass with different groups of feeds; (B) And feeding liver fat synthesis related gene expression level bar graphs of largemouth black bass by different groups of feeds. LS: a low starch group; HS: a high starch group; HSP's: high starch + lactobacillus plantarum group. ppar alpha, peroxisome proliferator activated receptor alpha; hsl, hormone sensitive lipase; atgl, fatty triglyceride lipase; pepck, phosphoenolpyruvate carboxykinase; ppar gamma, peroxisome proliferator-activated receptor gamma; srebp1, sterol regulatory factor binding protein 1; fas, fatty acid synthase; accα, acetyl-CoA carboxylase α. * P <0.05, < P <0.01, < P <0.001.
Detailed Description
The following examples are further illustrative of the invention and are not intended to be limiting thereof.
The Lactobacillus plantarum used in the examples below was derived from the Guangdong province microorganism strain collection (GDMCC) and was numbered GDMCC1.140.
In the present invention, the culture medium used for culturing lactobacillus plantarum is as follows:
the liquid MRS broth culture medium formula is as follows: 10.0g of casein enzyme digest, 10.0g of beef extract powder, 4.0g of yeast extract powder, 2.0g of triammonium citrate, 5.0g of sodium acetate, 0.2g of magnesium sulfate, 0.05g of manganese sulfate, 2.0g of dipotassium hydrogen phosphate, 20.0g of glucose, 1.0g of tween-80 and pH 5.7+/-0.2. Distilled water 1000mL. Autoclaving at 121℃for 15min.
The solid MRS broth medium was supplemented with 15g agar per liter.
In the invention, the recovery and preservation of lactobacillus plantarum GDMCC 1.140:
(1) Resuscitates the lactobacillus plantarum freeze-dried powder on an ultra-clean workbench. mu.L of MRS liquid culture medium was sucked up with a sterile gun head, dripped into a freeze-dried tube, and gently shaken until it was dissolved.
(2) All bacterial suspension was aspirated, inoculated on MRS solid medium plates and incubated at 37℃for 48h at rest.
(3) After the colony of the monoclonal bacteria had grown, the monoclonal bacteria were picked up by a sterile gun head into a 1.5mL centrifuge tube containing 500. Mu.L of medium and were subjected to stationary culture at 37℃for 48h. 500 μl of sterile 30% glycerol was then added.
(4) The selected monoclonal colonies were confirmed to be Lactobacillus plantarum by sequencing and comparison with NCBI (https:// blast. NCBI. Lm. Nih. Gov/blast. Cgi). Lactobacillus casei with 30% glycerol was deposited as a seed in a-80℃freezer.
In the invention, lactobacillus plantarum is subjected to amplification culture, collection and concentration:
(1) In an ultra clean bench, 20. Mu.L of Lactobacillus plantarum strain was inoculated into 15mL of liquid medium with a sterile gun head.
(2) The inoculated liquid culture medium is placed in a constant temperature incubator at 37 ℃ for standing for 48 hours.
(3) Centrifuging 4000g of the bacterial liquid at 4deg.C for 10 min, discarding the supernatant on an ultra-clean bench, washing with sterile water for 3 times, and suspending in sterile water to a concentration of about 10 8 -10 9 CFU/mL was placed in a refrigerator at 4deg.C for use.
Cultivation of experimental fish
Prior to the test, the largemouth bass was domesticated for 14 days and fed with low starch feed twice daily. The micropterus salmoides are cultivated in glass cylinders, all the glass cylinders are kept in a natural light/dark state, the dissolved oxygen is more than 6.04mg/L, the temperature is 28+/-1 ℃, the pH is about 7.2, and the nitrite and ammonia nitrogen concentration is lower than 0.1mg/L.
Example 1
The influence of the lactobacillus plantarum on liver health of the micropterus salmoides is detected, and the specific experimental operation steps are as follows:
(1) 225 healthy and similar largehead jewfish (initial body weight of 12.54.+ -. 0.02 g) were randomly divided into 3 groups (low starch group LS, high starch group HS, high starch+Lactobacillus plantarum group HSP), each group was set with 3 replicates, and allocated to 9 glass jars, 25 fish per jar. The cultivation period is 9 weeks, and different groups of lipid feeds such as nitrogen and the like are fed by feeding at 9 am and 5 pm every day, wherein the lipid feeds comprise low-starch group feed (LS group, 10% starch level), high-starch group feed (HS group, 20% starch level), high-starch+lactobacillus plantarum group feed (HSP group, 20% starch level evenly sprayed lactobacillus plantarum, and the final concentration is about 10) 7 CFU/g feed).
(2) After 9 weeks, the test micropterus salmoides are fasted for 1 day, and then sampled, dissected and weighed to obtain liver tissues, and the liver tissues are used for measuring indexes such as liver components, liver antioxidant enzyme activity, liver sections and the like.
As shown in fig. 1 and 2, the liver volume ratio of the micropterus salmoides in the HS group is significantly higher than that in the LS group, while the liver volume ratio of the micropterus salmoides in the HSP group is significantly lower than that in the HS group (fig. 1A). The liver fat content was significantly higher in the HS group than in the LS group, while the liver fat content was significantly lower in the HSP group than in the HS group (fig. 1B). The activities of superoxide dismutase and catalase of the HSP group micropterus salmoides are obviously higher than those of the HS group; the malondialdehyde content of the HS group is significantly higher than that of the LS group, whereas the malondialdehyde content of the HSP group is significantly lower than that of the HS group (fig. 2A). As can be seen from the results of liver sections, the livers of the HS group had a significant fat infiltration, more nuclei were extruded to the cell edges, severe nuclei disappeared and lipid vacuoles occurred, compared to the LS group, while the HSP group had significantly reduced lipid droplets, and significantly improved conditions of fat infiltration and hepatocyte damage, compared to the HS group (fig. 2B). The results show that the addition of the lactobacillus plantarum can obviously reduce the liver body ratio and liver fat deposition of the high-starch group, improve the liver oxidation resistance of the micropterus salmoides, relieve the liver cell injury caused by the high-starch feed and improve the starch tolerance of the micropterus salmoides.
Example 2
The influence of lactobacillus plantarum on intestinal microorganisms of the largemouth black bass is detected, and the specific experimental operation steps are as follows:
after 9 weeks of cultivation as described in example 1, the test micropterus salmoides were fasted for 1 day, and then sampled, dissected, and weighed to obtain intestinal contents of the intestinal tissue for intestinal microbiome determination. After the DNA extraction was completed, 16S V3-V4 region was selected and PCR amplification was performed using universal primers 338F and 806R, the amplified region being about 450bp in length. After quality detection of the extracted DNA, 3 samples per group were randomly selected for IlluminaMiSeq library preparation and sequencing. And splicing reads of each sample by using FLASH, filtering to obtain high-quality Tags data, and comparing the Tags with a database to remove a chimeric sequence to finally obtain effective data. The effective sequences were clustered into OTUs (Operational Taxonomic Units) using Uparse software, and then species annotation analysis and Alpha diversity analysis were performed using the Mothur method with the SSUrRNA database of SILVA.
The experimental results are shown in fig. 3, with the highest number of OTUs of intestinal microorganisms in HSP group, followed by LS group and HS group (fig. 3A); LS, HS and HSP groups contained 162, 113 and 236 unique OTUs, respectively. The Simpson index was significantly reduced for both the LS and HSP groups compared to the HS group, with higher averages of Shannon, chao and Ace indices for both the LS and HSP groups, but no significance was achieved (FIG. 3B). At the phylum level, the ratio of the fusobacterium in the LS group and the HSP group is the largest, while the ratio of the Proteus in the HS group is the largest, which is about 2 times that of the LS group and the HSP group. In the HS group, the proportion of the Thick-walled bacteria was only 1/7 of the LS group and the HSP group (FIG. 3C). At the genus level, the intestinal microbiota mainly comprises Cetobacterium (Cetobacterium), achromobacter (Achromobacter), romboutsia and Plasiomonas. Furthermore, the relative abundance of Achromobacter was significantly reduced in LS and HSP groups compared to HS group, while the relative abundance of romiboutsia was significantly increased (fig. 5B). The results prove that the lactobacillus plantarum can restore the decrease of Alpha diversity of intestinal microorganisms of the micropterus salmoides caused by high-starch feed, change the composition of intestinal flora structures of the micropterus salmoides, maintain the steady state of the intestinal microorganisms and improve the sugar tolerance capability of the micropterus salmoides. .
Example 3
The method for detecting the influence of the lactobacillus plantarum on the liver glycolipid metabolism of the largemouth black bass comprises the following specific operation steps: after 9 weeks of culture of the black perch according to example 1, the experimental black perch was fasted for 1 day, followed by sampling and dissection to obtain liver tissue for liver transcriptome and QPCR assays.
Transcriptome assay: total RNA was extracted from liver samples using TRIzol. RNA quality and quantity were measured, cDNA libraries were synthesized, and the libraries were pooled and sequenced on an Illumina NovaSeq 6000 platform. The expression level of the transcripts was calculated according to the per million reads Transcript (TPM) method. Differentially Expressed Genes (DEGs) were identified using DESeq2 software and set to |log2FC|+.1 and FDR+.0.05. KEGG enrichment analysis of DEGs is based on P.ltoreq.0.05.
QPCR assay: total RNA was extracted from liver samples using the total RNA extraction kit (BioFlux, china). Reverse transcription was performed using PrimeScript TMRT kit (Takara, japan). PCR amplification was performed by SYBR Green Master Mix (Toyobo, japan) in the CFX Connect Real-Time system (Bio-Rad Laboratories, USA), reaction program: 3min at 95 ℃;95 ℃ for 30s,60 ℃ for 30s,40 cycles; 72 ℃ for 1min. Relative expression level of genes according to 2 -ΔΔCT The method performs the calculation.
The results of liver transcriptome KEGG enrichment analysis are shown in fig. 4, and in comparison of HSP group and HS group, DEGs are significantly enriched in PPAR signaling pathway, tricarboxylic acid cycle, peroxisome, interconversion of pentose and glucuronic acid, ascorbic acid and aldehyde acid metabolism, unsaturated fatty acid synthesis and other pathways. The QPCR assay results are shown in fig. 5, where mRNA expression levels of HSP group lipolytic related genes (ppar a, hsl and atgl) were significantly up-regulated compared to HS group (fig. 5A). Furthermore, the expression of the genes involved in lipid synthesis (pepck, pparγ, srebp1 and fas) was significantly up-regulated in the HS group compared to the LS group, whereas the expression levels of these genes were significantly down-regulated in the HSP group compared to the HS group; mRNA expression level trends for the three groups of acc α were the same as described above, but did not reach significant levels (fig. 5B). The results show that the lactobacillus plantarum can promote liver lipolysis and inhibit high sugar-induced fat synthesis by regulating the liver PPAR signal pathway, tricarboxylic acid circulation and other pathways of the largehead jewflower.
Claims (7)
1. Use of lactobacillus plantarum formulation for improving fish carbohydrate tolerance.
2. The use according to claim 1, wherein the lactobacillus plantarum is derived from the collection of microorganisms of the cantonese province under the designation GDMCC1.140.
3. The use according to claim 1, wherein the lactobacillus plantarum is cultivated with MRS broth at 37 ℃ for 48h, washed three times with sterile water and dissolved in sterile water at a concentration of 10 8 -10 9 CFU/mL。
4. The use according to claim 1, wherein the fish is micropterus salmoides.
5. The use according to claim 4, wherein the lactobacillus plantarum is uniformly sprayed into the feed of the largemouth bass at a final concentration of about 10 7 CFU/g feed.
6. The method according to claim 5, wherein the new bacterial liquid is sprayed every 48 hours.
7. The use according to claim 1, wherein the lactobacillus plantarum formulation maintains intestinal microbial homeostasis of jewfish, regulates the hepatic PPAR signaling pathway and the tricarboxylic acid circulating pathway, thereby regulating glycolipid metabolic disorders, and achieves relief of jetfish hepatic fat deposition.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311194904.8A CN116998593B (en) | 2023-09-15 | 2023-09-15 | Application of lactobacillus plantarum in preparation for improving fish sugar tolerance |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311194904.8A CN116998593B (en) | 2023-09-15 | 2023-09-15 | Application of lactobacillus plantarum in preparation for improving fish sugar tolerance |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN116998593A true CN116998593A (en) | 2023-11-07 |
| CN116998593B CN116998593B (en) | 2024-06-28 |
Family
ID=88571174
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202311194904.8A Active CN116998593B (en) | 2023-09-15 | 2023-09-15 | Application of lactobacillus plantarum in preparation for improving fish sugar tolerance |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116998593B (en) |
Citations (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101073585A (en) * | 2006-05-18 | 2007-11-21 | 上海创博生态工程有限公司 | Microbial preparation for improving eel liver growth and its making method |
| KR20080040134A (en) * | 2006-11-02 | 2008-05-08 | 문상욱 | Composition and method for promoting proliferation of beneficial microorganisms |
| KR101658655B1 (en) * | 2015-06-30 | 2016-09-23 | (주)크린바이오 | Novel STRAIN of Lactobacillus plantarum Isolated from Anguilla japonica and Probiotics for Fish Using Thereof |
| CN106387317A (en) * | 2016-08-31 | 2017-02-15 | 上海绿博生物科技发展有限公司 | Microorganism feed additive capable of protecting pig livers and preparation method of microorganism feed additive |
| CN107821789A (en) * | 2017-11-08 | 2018-03-23 | 广州智龙生物科技有限公司 | A kind of biologic ferment for improving fishes and shrimps intestinal health degree and its preparation method and application |
| CN108935939A (en) * | 2018-08-02 | 2018-12-07 | 合肥河多宝农业开发有限公司 | Lipotropic rheum officinale fish feed additive |
| CN110226673A (en) * | 2019-07-08 | 2019-09-13 | 中国水产科学研究院淡水渔业研究中心 | The compound formulation and preparation method thereof of intestines is good in liver protection in a kind of cultivation of Micropterus salmonoides |
| CN115381005A (en) * | 2022-08-25 | 2022-11-25 | 中国农业科学院饲料研究所 | Application of lactobacillus plantarum CICC 6240 in reducing antibiotic residues in aquatic product bodies |
| CN115895977A (en) * | 2022-12-29 | 2023-04-04 | 华熙生物科技股份有限公司 | Lactobacillus paracasei and application thereof |
| CN116083262A (en) * | 2022-07-05 | 2023-05-09 | 江苏省苏微微生物研究有限公司 | Lactobacillus plantarum strain with aquatic pathogenic bacteria antagonistic property and preparation and application of preparation thereof |
| CN116139177A (en) * | 2023-03-28 | 2023-05-23 | 四川高福记生物科技有限公司 | Lactobacillus plantarum composition for preventing and treating metabolic diseases and application thereof |
| CN116508914A (en) * | 2023-06-19 | 2023-08-01 | 广东海洋大学 | Composite additive and method for improving utilization rate of high-starch feed by micropterus salmoides |
-
2023
- 2023-09-15 CN CN202311194904.8A patent/CN116998593B/en active Active
Patent Citations (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101073585A (en) * | 2006-05-18 | 2007-11-21 | 上海创博生态工程有限公司 | Microbial preparation for improving eel liver growth and its making method |
| KR20080040134A (en) * | 2006-11-02 | 2008-05-08 | 문상욱 | Composition and method for promoting proliferation of beneficial microorganisms |
| KR101658655B1 (en) * | 2015-06-30 | 2016-09-23 | (주)크린바이오 | Novel STRAIN of Lactobacillus plantarum Isolated from Anguilla japonica and Probiotics for Fish Using Thereof |
| CN106387317A (en) * | 2016-08-31 | 2017-02-15 | 上海绿博生物科技发展有限公司 | Microorganism feed additive capable of protecting pig livers and preparation method of microorganism feed additive |
| CN107821789A (en) * | 2017-11-08 | 2018-03-23 | 广州智龙生物科技有限公司 | A kind of biologic ferment for improving fishes and shrimps intestinal health degree and its preparation method and application |
| CN108935939A (en) * | 2018-08-02 | 2018-12-07 | 合肥河多宝农业开发有限公司 | Lipotropic rheum officinale fish feed additive |
| CN110226673A (en) * | 2019-07-08 | 2019-09-13 | 中国水产科学研究院淡水渔业研究中心 | The compound formulation and preparation method thereof of intestines is good in liver protection in a kind of cultivation of Micropterus salmonoides |
| CN116083262A (en) * | 2022-07-05 | 2023-05-09 | 江苏省苏微微生物研究有限公司 | Lactobacillus plantarum strain with aquatic pathogenic bacteria antagonistic property and preparation and application of preparation thereof |
| CN115381005A (en) * | 2022-08-25 | 2022-11-25 | 中国农业科学院饲料研究所 | Application of lactobacillus plantarum CICC 6240 in reducing antibiotic residues in aquatic product bodies |
| CN115895977A (en) * | 2022-12-29 | 2023-04-04 | 华熙生物科技股份有限公司 | Lactobacillus paracasei and application thereof |
| CN116139177A (en) * | 2023-03-28 | 2023-05-23 | 四川高福记生物科技有限公司 | Lactobacillus plantarum composition for preventing and treating metabolic diseases and application thereof |
| CN116508914A (en) * | 2023-06-19 | 2023-08-01 | 广东海洋大学 | Composite additive and method for improving utilization rate of high-starch feed by micropterus salmoides |
Also Published As
| Publication number | Publication date |
|---|---|
| CN116998593B (en) | 2024-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zhang et al. | Effects of dietary Bacillus licheniformis on growth performance, intestinal morphology, intestinal microbiome, and disease resistance in common carp (Cyprinus carpio L.) | |
| CN113080111A (en) | Application of bile acid in improving intestinal health and cultivation survival rate of cynoglossus semilaevis | |
| Reyes‐Becerril et al. | Probiotic properties of Debaryomyces hansenii BCS004 and their immunostimulatory effect in supplemented diets for gilthead seabream (Sparus aurata) | |
| CN114561318B (en) | Lactobacillus murinus and application thereof in treatment of type II diabetes | |
| CN118028155B (en) | Novel probiotics, fermented coconut water metaplasia and application thereof in poultry feed additive | |
| CN113678942B (en) | Application of chlorella | |
| CN111676145B (en) | Saccharomyces cerevisiae and application thereof in aquaculture | |
| CN116998593B (en) | Application of lactobacillus plantarum in preparation for improving fish sugar tolerance | |
| CN111676155B (en) | Bacillus licheniformis and application thereof in aquaculture | |
| WO2024217596A1 (en) | Use of lactobacillus plantarum in preparation for promoting sugar utilization ability of fish | |
| CN113960320B (en) | Application of lactobacillus plantarum P8 in DEX-induced broiler chicken oxidative stress regulation and control | |
| CN111733088B (en) | Micro-ecological composite additive containing saccharomyces cerevisiae and application thereof | |
| CN111676158B (en) | Pediococcus acidilactici and application thereof in aquaculture | |
| CN110050906A (en) | Hydrolysable Tannins is improving the application in prawn growth performance and gut of shrimp bacterial abundance | |
| CN117089508B (en) | Method for preparing acid-resistant lactobacillus based on metal ion pre-stress and application of method | |
| NL2036281B1 (en) | Application of 5-hmf in feed additives and feed for promoting growth and improving immunity of seriola lalandi | |
| Pudova et al. | Effect of Bacillus pumilus 3-19 protease on growth parameters and gut microbiome of broiler chickens | |
| Li et al. | Effects of silkworm pupae powder on growth performance, muscle fatty acid composition, and intestinal function in mandarin fish (Siniperca chuatsi) | |
| Li | Research on the Bacterial Fermentation of Peanut Meal and Their Effects on the Production Performance of Broilers | |
| Yang et al. | Comparative studies on the intestinal health of wild and cultured ricefield eel (Monopterus albus) | |
| CN116751710A (en) | Rabbit-derived lactobacillus johnsonii and application thereof | |
| CN118547088A (en) | Method, apparatus and computer readable storage medium for identifying fish intestinal microbial homeostasis or imbalance | |
| CN118806800A (en) | Application of bacillus coagulans BC66 strain in preparation of probiotics for regulating fish sugar metabolism | |
| Zhao et al. | Isolation, identification, and evaluation of intestinal bacteria in Macrobrachium rosenbergii | |
| Guo et al. | Effects of different feeding patterns on growth, enzyme activity, and intestinal microbiome of the juvenile Pacific abalone Haliotis discus hannai |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |